SAN FRANCISCO, April 15, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of the pending securities class action and the upcoming May 5, 2026 lead plaintiff deadline. The firm urges investors who purchased Soleno common stock between March 26, 2025, and November 4, 2025 (the "Class Period"), and suffered significant losses to submit your losses now.
Read more at prnewswire.com
INVESTOR DEADLINE: Soleno Therapeutics, Inc. (SLNO) Investors with Substantial Losses Have Opportunity to Lead the Soleno Class Action Lawsuit- Hagens Berman
Provided By PR Newswire – Last update: